This Migraine Drug will be a BIG HEADACHE for Lundbeck!!!!

Discussion in 'Lundbeck' started by anonymous, Nov 6, 2019 at 7:17 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Maybe because the current Lundbeck employees are looking for a way out and are asking us what better opportunities are out there. It is also a way for them to complain to people that know the dysfunction of Lundbeck without having to tell their coworkers. We are allowing them to vent and share their frustration, from the people that get it!
     

  2. anonymous

    anonymous Guest

    I’m guessing the person who left Lundbeck for greener pastures and keeps posting on this board isn’t too happy in their new role.
     
  3. anonymous

    anonymous Guest

    This is a prime example of a typical Lundbeck manager. They will never get hired as managers in any other company. This particular manager in New England, is hated by every single one of her reps. Shes a narcissit micro manger that makes every single day HELL. I pray she gets laid off and gets a job as a rep and has a manager like her. If you see any openings in New England RUN!! shes a nightmare.
     
  4. anonymous

    anonymous Guest

    She is not a typical Lundbeck NEURO Manager. She came from Psych where they are driven by metrics and micromanagement. She clearly doesn’t fit Neuro. Good luck.
     
  5. anonymous

    anonymous Guest

    Actually the NE Neuro manger before the current one was actually worse if that's even possible. She exited Lundbeck when a flury of lawsuits from her actions started to flood Lunbeck. I've heard the Tenn- Carolina Neuro mananger is a redneck nightmare that knows nothing about the drug and hides behind his tenured reps, but is worthless and the text book example of a micromanager. Its a profile Lundbeck looks for in its managers. Its a dumping ground for managers who either got fired, pushed out and cant get hired by any other pharma company.
     
  6. anonymous

    anonymous Guest

    Well you heard wrong and couldn’t be further from the truth
     
  7. anonymous

    anonymous Guest

    The NE neuro manager did not come from psych... and there were no lawsuits when the previous manager left. Just a fun little fact check for you! Don’t believe everything you read on the internet, kiddos.
     
  8. anonymous

    anonymous Guest

    I wouldn't worry too much about this “opportunity”. The view from most migraine specialists is that this product will be used in 15% of patients at best.

    Good luck recouping $2B!
     
  9. anonymous

    anonymous Guest

    I wouldn’t worry too much about the managers. In a year there will be no NS1 salesforce. I would worry about the next opportunity.
     
  10. anonymous

    anonymous Guest

    I think your "Fact checker is incorrect." Good try covering up the truth about the lawsuits she left behind. She can run to a new company but she can't hide from the past and the truth.
     
  11. anonymous

    anonymous Guest

    She was one of the most fair and principled managers at lundbeck. You also don’t know anything about her alleged track record. R_!
     
  12. anonymous

    anonymous Guest

    We all do. I'm pretty sure this is the manager herself trying to convinece us all of her innocence, but we know the truth and her new company will find out soon enough when her true micormanging narcissistic side busts the dam door down like the kool aid man!
     
  13. anonymous

    anonymous Guest

    15% of the patient population is a lot. If we get 15%, this will be most successful drug in the history of medicine.
     
  14. anonymous

    anonymous Guest

    Typical Lundbeck rep.

    Which patient population are you dreaming about? Total migraine—not your market, acute migraine—not your market, chronic migraine—now your getting warm. Now break it down to those failing other therapies and already launched CGRPs. Now break it down further to those docs with infusion capability. Now break it down to those willing to do the paperwork to justify this and make less than on Botox. That’s your 15%.

    Good luck
     
  15. anonymous

    anonymous Guest

    Most insurances are going to require the patient has failed Botox to even try this IV formulation, And then as posted above the patient most likely will have to go to a different office (infusion ctr) than the neurologist who prescribed it to actually have it infused into them, not many regular Neuro offices actually due IV infusion in their office setting.
     
  16. anonymous

    anonymous Guest

    Will the migraine reps have the super vis aids that we do in psych? If so, you can bet they will also take 1.5% market share like we did with Trintellix! We will be floating in money! Good times here we come!
     
  17. anonymous

    anonymous Guest

    Anyone who received an offer for the migraine drug can you tell me how the process went did the manager reach out with the offer or was it HR ??
    Also what consists in the background check ?
    Would bad credit prevent someone from getting the job ?
    Or what about 1 or 2 traffic tickets would that also prevent someone from getting the job they are not DWI’s though ?
    Thx
     
  18. anonymous

    anonymous Guest

    You’re a fucking r*****. You’re perfect for Lundbeck. Don’t fret; I’m sure you got it.
     
  19. anonymous

    anonymous Guest

    There is a new hire opening in my area-would you recommend applying? Do you think this division is stable?
     
  20. anonymous

    anonymous Guest

    All that is perfectly fine, traffic tickets are actually encouraged. However, posting the same stupid questions on 3 different threads is frowned upon by managers